Experimental murine leishmaniasis and the Th1/Th2 cell concept

Tokai Journal of Experimental and Clinical Medicine

Volumn 23, Issue 6, 1998, Pages 347-350

  Lohoff, Michael ^a,b   Gessner, Andre ^a   Bogdan, Christian ^a   Röllinghoff, Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

IFN ; IL 12; IL 4; Leishmaniosis; Th1 cell; Th2 cell

Indexed keywords

ANIMAL; DISEASE MODEL; HUMAN; IMMUNOLOGY; MOUSE; REVIEW; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LEISHMANIASIS, CUTANEOUS; MICE; TH1 CELLS; TH2 CELLS;

EID: 0032222661     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Moll H, Fuchs H, Blank C, Rollinghoff M: Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen- specific T cells. Eur J Immunol ; 23: 1595-1601, 1993.
2. Howard JG, Hale C, Liew FY: Immunological regulation of experimental cutaneous leishmania sis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica. J Exp Med ; 153: 557-568, 1981.
3. Titus RG, Ceredig R, Cerottini JC, Louis JA: Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmania sis in genetically-susceptible BALB/c mice. J Immunol ; 135: 2108-2114, 1985.
4. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol ; 15: 323-350, 1997.
5. Stenger S, Thuring H, Rollinghoff M, Bogdan C: Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med ; 180: 783-793, 1994.
6. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature ; 375: 408-411, 1995.
7. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogrlan C: Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity ; 8: 77-87, 1998.
8. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S: Macrophage deactivating factor and transforming growth factors- beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol ; 145: 940-944, 1990.
9. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA: Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol ; 145: 4290-4297, 1990.
10. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM: CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med ; 179: 1367-1371, 1994.
11. Barral Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR, Reed SG: Transforming growth factor-beta in leishmania 1 infection: a parasite escape mechanism. Science ; 257: 545-548, 1992.
12. Laskay T, Rollinghoff M, Solbach W: Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur J Immunol ; 23: 2237-2241, 1993.
13. Mitchell GF, Curtis JM, Scollay RG, Handman E: Resistance and abrogation of resistance to cutaneous leishmania sis in reconstituted BALB/c nude mice. Aust J Exp Biol Med Sci ; 59: 539-554, 1981.
14. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A: Immunoregulation of cutaneous leishmania sis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med ; 168: 1675-1684, 1988.
15. Heinzel FP, Sadick MD, Mutha SS, Locksley RM: Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmania sis. Proc Natl Acad Sci U S A ; 88: 7011-7015, 1991.
16. Chatelain R, Varkila K, Coffman RL: IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol ; 148: 1182-1187, 1992.
17. Wershil BK, Theodos CM, Galli SJ, Titus RG: Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol ; 152: 4503-4571, 1994.
18. Bretscher PA, Wei G, Menon JN, Bielefeldt Ohmann H: Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science ; 257: 539-542, 1992.
19. Sacks DL, Scott PA, Asofsky R, Sher FA: Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol ; 132: 2072-2077, 1984.
20. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med ; 177: 1505-1509, 1993.
21. Shankar AH, Titus RG: T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med ; 181: 845-855, 1995.
22. Schulte T, Kurrle R, Rollinghoff M, Gessner A: Molecular characterization and functional abalysis of murine Interleukin 4 receptor allotypes. J Exp Med ; 186: 1-11, 1997.
23. Gorham JD, Guler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM: Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Pror Natl Acad Sci U S A ; 93: 12467-12472, 1996.
24. Mock B, Blackwell J, Hilgers J, Potter M, Nacy C: Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur J Immunogenet ; 20: 335-348, 1993.
25. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, Mak TW: Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity ; 6: 681-689, 1997.
26. Demant P, Lipoldova M, Svobodova M: Resistance to Leishmania major in mice [letter]. Science ; 274: 1392-1393, 1996.
27. Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA: In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NKL1-. Eur J Immunol ; 25: 3298-3307, 1995.
28. Launois P, Maillard I, Pingel S, Swihart KG, Xenarios I, Acha Orbea H, Diggelmann H, Locksley RM, MacDonald HR, Louis JA: IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity ; 6: 541-549, 1997.
29. Julia V, Rassoulzadegan M, Glaichenhaus N: Resistance to Leishmania major induced by tolerance to a single antigen. Science ; 274: 421-423, 1996.